Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10


Quiros, S; Roos, WP; Kaina, B

Rad51 and BRCA2-New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs

PLOS ONE. Bd. 6. H. 11. 2011 S. -


Kuppers, M; Faust, D; Linz, B et al.

Regulation of ERK-1/2 activity upon contact inhibition in fibroblasts

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Bd. 406. H. 3. 2011 S. 483-487


Reichert, S; Rodel, C; Mirsch, J et al.

Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma

RADIOTHERAPY AND ONCOLOGY. Bd. 101. H. 1. 2011 S. 51-58


Osmak, M; Cimbora-Zovko, T; Brozovic, A et al.

Synthesis and biological evaluation of 4-nitro-substituted 1,3-diaryltriazenes as a novel class of potent antitumor agents

FEBS JOURNAL. Bd. 278. 2011 S. 333-333


Cimbora-Zovko, T; Brozovic, A; Piantanida, I et al.

Synthesis and biological evaluation of 4-nitro-substituted 1,3-diaryltriazenes as a novel class of potent antitumor agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. Bd. 46. H. 7. 2011 S. 2971-2983



Kaina, B; Tomaszowski, KH

Targeting of cancer cells with a glucose-conjugated DNA-repair-inhibitor

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 101-101


Dietrich, C

The AHR in the Control of Cell Cycle and Apoptosis

R. Pohjanvirta (edt.) The Ah Receptor in Biology and Toxicology. John Wiley & Sons, Inc. 2011


Berdelle, N; Quiros, S; Efferth, T et al.

The influence of the TCM drug artesunate on the sensitivity of tumor cell lines and his cytotoxic an genotoxic activity

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 101-101